UMIN ID: UMIN000054100
Registered date:10/04/2024
Development of a Scoring Model to Predict Completion of Chemoradiotherapy for Inoperable Stage III NSCLC
Basic Information
| Recruitment status | Pending |
|---|---|
| Health condition(s) or Problem(s) studied | Inoperable Stage III Non-Small Cell Lung Cancer |
| Date of first enrollment | 2024/05/01 |
| Target sample size | 1288 |
| Countries of recruitment | Japan |
| Study type | Observational |
| Intervention(s) |
Outcome(s)
| Primary Outcome | Percentage of treatment completed = Percentage of protocol treatment completed for each study |
|---|---|
| Secondary Outcome |
Key inclusion & exclusion criteria
| Age minimum | Not applicable |
|---|---|
| Age maximum | Not applicable |
| Gender | Male and Female |
| Include criteria | |
| Exclude criteria | Exclude the following cases. (1) Cases in which completion of treatment was not noted. |
Related Information
| Primary Sponsor | Hamamatsu University School of Medicine |
|---|---|
| Secondary Sponsor | |
| Source(s) of Monetary Support | Self-funding |
| Secondary ID(s) |
Contact
| public contact | |
| Name | Masato Karayama |
| Address | Hanadayama 1-20-1, Hamamatsu, Shizuoka Japan 4313192 |
| Telephone | 053-435-2491 |
| karayama@hama-med.ac.jp | |
| Affiliation | Hamamatsu University School of Medicine Cancer Center |
| scientific contact | |
| Name | Takafumi Suda |
| Address | Hanadayama 1-20-1, Hamamatsu, Shizuoka Japan |
| Telephone | 0534352263 |
| suda@hama-med.ac.jp | |
| Affiliation | Hamamatsu University School of Medicine Department of Internal Medicine, Second Devision |